Physician-scientist, Lymphoma oncologist @DanaFarber | Tweets are my own and not medical advice. #Lymphoma
Boston, MA
- Tweets 24
- Following 311
- Followers 209
- Likes 193
Erin Parry, MD PhD retweeted
Excited to share our latest publication from the Lili Wang lab! by Prajish Iyer et al.🌟 MGA deletion drives Richter’s transformation by modulating mitochondrial OXPHOS, highlighting new therapeutic avenues. @DanilovLab @CllSociety
science.org/doi/10.1126/scit…
1
5
17
930
Erin Parry, MD PhD retweeted
#AACRlymph24 cochair Ari M. Melnick, Sandrine Roulland, and Erin M. Parry discussed "Lymphoma Clonal Precursors and Transformation" in a plenary session at the Fourth AACR International Meeting on Advances in Malignant Lymphoma. @LabMelnick @SRoulland @ErinMParry
2
12
2,798
Erin Parry, MD PhD retweeted
🔬Are you an early-career researcher ready to take the next step in your research career? Apply for ASH & @EHA_Hematology's #TRTH program! Read the testimonials to see what past participants had to say about their experiences! Apply by June 20: ow.ly/GoW250RJTko
#hematology
13
16
6,581
RT @Lachelle_Dawn: #ASH23 is about running from a meeting in the Marriot all the way to room 28 in the conference center to see @beckyzon r…
2
Erin Parry, MD PhD retweeted
At #ASH23, Reid Merryman, MD @DanaFarber reveals results from a pilot study that uses circulating tumor DNA to reliably predict relapse in patients with diffuse large B-cell lymphoma (#DLBCL).
Press release: ms.spr.ly/6013iTO1S
3
10
3,179
Erin Parry, MD PhD retweeted
#ASH23 - Abstract 223
Outstanding presentation by @Dr_KatieM 👏🏻👏🏻👏🏻
Response to axi-cel is associated with:
✅The presence of > 0.5% circulating B-cells at baseline
✅Higher ALC/AMC at baseline
✅Enrichment of clonally expanded
CD8+ TEM cells in IP
#CARTcell
4
10
1,399
Erin Parry, MD PhD retweeted
@inhyeahn from @DanaFarber presenting at #iwcll2023 on one of the largest datasets ever reported for BTKi resistance mechanisms in CLL @iwCLL
4
36
4,380
Erin Parry, MD PhD retweeted
Congratulations to Dr. Susan O’Brien (@UCIrvineHealth) and Dr. Catherine Wu (@DanaFaber), recipients of the iwCLL Binet-Rai Medals for outstanding contributions to CLL research at #iwCLL2023
1
20
148
18,017
Had a great time at #iwCLL2023 sharing our work @RomainGuieze @lesh_lab @getz_lab Stilgenbauer and Wu in an amazing genomics session! Fascinating talks by Cindy Hahn @FerranNadeu @PaulineRobbe
@iwCLL2023 So many great contributions to the #Richter biology this year ! Bravo to @ErinMParry and @FerranNadeu for such great talks !
1
14
1,384
Congrats Elisa!
#AndJustLikeThat 🌟the ten Hacken lab is officially live from @WeillCornell NYC! 🌟
Join me in this new exciting adventure if you are interested in understanding chronic lymphocytic leukemia and Richter’s syndrome through mouse modeling (and more!). Recruiting at all levels!
2
532
Erin Parry, MD PhD retweeted
The story behind Venetoclax, a new cancer therapy, started nearly 40 years ago. How it went from the discovery of a protein to a game-changing cancer drug is a story of persistence and momentum and the first episode of season two of the Unraveled podcast. podcasts.apple.com/us/podcas…
3
7
2,208
Erin Parry, MD PhD retweeted
During an early morning session here at #ASH22, there’s an overflow crowd for @DanaFarber Caron Jacobson’s, MD, MMSc, presentation on her findings from her investigator-initiated study of CAR T-cell therapy for CNS lymphoma. There’s not an empty seat in the ballroom.
2
5
48
Erin Parry, MD PhD retweeted
This was all only possible because of the study’s lead investigator and my incredible mentor @DrMDavids. Many, many thanks to him for the generous opportunity to present these results yesterday! #ASH22 @DanaFarber @DanaFarberNews
Presenting her findings to a packed auditorium, @DanaFarber Christine Ryan, M.D. explains how a triple regimen of AVO was shown highly effective in patients with high-risk forms of Chronic Lymphocytic Leukemia. #ASH22
2
2
40
Erin Parry, MD PhD retweeted
In vivo modeling of #CLL transformation to #Richtersyndrome reveals convergent evolutionary paths and therapeutic vulnerabilities, by @etenhacken et al.
bit.ly/3uxoFRe
@DanaFarberNews @DanaFarber @harvardmed #chroniclymphocyticleukemia
1
5
7
Erin Parry, MD PhD retweeted
1/Very excited to see this out online at @BCD_AACR!
Check out our novel mouse models reflective of chronic lymphocytic leukemia (CLL) transformation into Richter’s syndrome achieved via combinatorial CRISPR-Cas9 gene editing!
aacrjournals.org/bloodcancer…
3
15
44
Erin Parry, MD PhD retweeted
@etenhacken has developed a new model for Richter's syndrome, the transition of #CLL to a high-grade lymphoma, which is the perfect context to study clonal evolution using #mtDNA mutations. Check out her brand new @BCD_AACR paper also released today! /4
aacrjournals.org/bloodcancer…
1
1
3
Erin Parry, MD PhD retweeted
Finally, we also saw mtDNA mutations that were further enriched in the Richter's model after transplant into a recipient animal. This demonstrates that - like in human - mitochondrial DNA mutations in mice can be dynamic markers of distinct subclones and differential chromatin./9
1
1
1
Erin Parry, MD PhD retweeted
🐭 Can mitochondrial DNA mutations track lineage in murine cancer models❓ Together w/ @etenhacken plus the mtDNA experts @LeifLudwig and @CalebLareau we investigated this question with mtscATAC-seq using Elisa's #CLL and #RS models. Out now in @CR_AACR./1
aacrjournals.org/cancerres/a…
3
24
91